Summaries
Let’s talk about weight guideline
Support your patients to manage their weight by initiating a conversation. This is a step-by-step guide to brief interventions with adults.
NICE type 2 diabetes prevention guideline
This Guidelines summary covers the identification of people at high risk of type 2 diabetes and the provision of interventions for them
FSRH overweight, obesity, and contraception guideline
Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese
NICE obesity guideline
A guideline summary on the identification and classification of overweight and obesity in children and adults, with advice on lifestyle and drug management
Let’s talk about weight in children guideline
This summary relates to families of 4–12-year-old children and young people, covering how to discuss weight, and support positive lifestyle changes.
Educational resources
Liraglutide 6 mg/ml solution for injection in pre-filled pen (Saxenda®) SMC2455
Information intended for UK healthcare professionals only. The production of this Guidelines card has been commissioned by Novo Nordisk Limited.
View Saxenda® (liraglutide 3 mg) Great Britain and Northern Ireland prescribing information and adverse event reporting information.
UK22SX00249
Date of preparation: June 2022
Management of obesity in primary care: a Guidelines algorithm
Information intended for UK healthcare professionals only. These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos.
Date of preparation: December 2021
Managing obesity in primary care
This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.